HD-OPM Archive
Topics › Statins

Elevated creatine kinase on a statin means muscle symptoms are real, not nocebo

Louis Nervegna · Apr 29, 2026 · ♥ 8 reactions · 28 comments · original Facebook post
Statins
AI summary & key facts

Louis explains that significantly elevated creatine kinase on a statin, after ruling out exercise, infection, trauma or hypothyroidism, indicates a genuine statin effect that is uncommon and more serious than ordinary myalgia.

Someone asked about this…
I think it’s important to understand.

If you have elevated creatine kinase (“muscle enzyme”) on a statin, then your muscle-related symptoms are very likely real. Nocebo effect will not cause this, as far as I am aware.

Something else could cause it (e.g. exercise, infections, trauma, hypothyroidism), but if you rule out these other things, then all you are left with is the statin as the cause. A significant elevation in creatine kinase is very uncommon with statins. It is more serious than ordinary muscle pain (myalgia) on a statin, which typically doesn’t involve significant elevations in creatine kinase. But it can occur in a small number of people, especially if they have a genetic susceptibility. This is a case where a physician would typically recommend that statins be stopped, or at least that the dose be reduced and the patient closely monitored. Speak to your doctor about this for more information, if you are concerned.

Some quick math:

Let’s assume that significant elevations in CK happen in about 0.2% of all statin users. (See below for justification of this number.) This is 2 per 1000. That means a facebook group our size with almost 7000 people will have around 14 people who experience this, assuming everyone took statins. If only 1/3 of our group too statins (closer to reality), then it would be around 4-5 people.


Here’s what Gemini AI has to say:

An elevation in creatine kinase (CK) while taking a statin is generally considered a marker of objective muscle damage ("true" myopathy) rather than the nocebo effect. While common muscle pain (myalgia) from statins often occurs with normal CK levels, a significant rise in this "muscle enzyme" indicates potential muscle inflammation, known as myositis.

Key Considerations Regarding Statin-Induced CK Elevation

Rule Out Other Causes: Before attributing the elevation to the statin, it is essential to exclude other causes, such as strenuous exercise, infection, trauma, hypothyroidism, or interactions with other medications (e.g., fibrates, some antifungals).

The Role of Exercise: Statin users may be more susceptible to elevated CK after intense, eccentric, or new exercise routines. However, prolonged moderate-intensity exercise is generally safe for those on statins.

Genetic Susceptibility: Some individuals are genetically susceptible to statin-induced muscle toxicity, such as those with specific variations in the SLCO1B1 gene, which can increase the risk of statin-induced myopathy.

Significance of Levels

Mild Elevation (<4x upper limit of normal): May sometimes be managed by dose reduction and close monitoring.

Significant Elevation (>10x upper limit of normal): Signals a high risk of rhabdomyolysis (a rare but severe condition involving serious muscle breakdown), warranting immediate discontinuation of the medication.

Next Steps: If your doctor has identified this elevated level in the absence of other factors, discontinuing the statin is the appropriate and standard medical advice to allow the enzyme levels and any symptoms to normalize.

"True" statin-associated muscle problems (more than just muscle pain) are rare, often occurring in less than 0.2% of patients per year, making this situation a specific case requiring medical intervention rather than a case of nocebo effect.

#statinsHD #creatininekinaseHD #noceboHD #myalgiaHD #myopathyHD #myositisHD #muscleHD

← newer: Extra virgin olive oil loses beneficial compounds fast; use older: GLP-1 doses that are too high can mute food noise and pleasu →